A systematic review on high-frequency spinal cord stimulation therapy for neuropathic pain

Authors

  • Yuanbo Zhao

DOI:

https://doi.org/10.61173/e0rer980

Keywords:

10kHz SCS, neuropathic pain, adverse impact

Abstract

Neuropathic pain is a complex, chronic pain caused by damage to the nervous system, affecting 6.9% to 10% of the population globally. In contemporary society, the therapeutic efficacy of high-frequency spinal cord stimulation (HF10) at 10 kHz has been confirmed by multiple studies and clinical tests, especially in alleviating pain associated with complex regional pain syndrome (CRPS), diabetes-related neuropathy and Peripheral nerve damage. HF10 therapy not only significantly reduces pain, but also avoids the paresthesia caused by traditional SCS during the treatment process. According to a SENZA study, 88% of participants reported greater than 50% pain reduction after one year, and HF10 excelled at improving daily activities and quality of life. In addition, HF10 treatment has fewer side effects and good long-term effects and is free of paresthesia, making it significantly cost-effective. These findings highlight the potential of HF10 as an innovative treatment in the management of chronic neuropathic pain, providing new hope for patients.

References

[1] Wikipedia contributors. Gate control theory. Wikipedia, 2024, August 27. https://en.wikipedia.org/wiki/Gate_control_ theory.

[2] Chen Y., Song X. Diabetic Neuropathic Pain: Directions for exploring Treatments. Biomedicines, 2024, 12(3): 589. https:// doi.org/10.3390/biomedicines12030589.

[3] Olmsted Z.T., Hadanny A., Marchese A.M., et al. Recommendations for neuromodulation in diabetic neuropathic pain. Frontiers in Pain Research, 2021, 2. https://doi. org/10.3389/fpain.2021.726308.

[4] Al‐Kaisy A., Van Buyten J., Amirdelfan K., et al. Opioid‐ sparing effects of 10 kHz spinal cord stimulation: a review of clinical evidence. Annals of the New York Academy of Sciences, 2019, 1462(1): 53-64. https://doi.org/10.1111/nyas.14236.

[5] Shealy C.N., Mortimer J.T., Reswick J.B. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth. Analg., 1967.

[6] Russo M.A., Volschenk W., Bailey D., et al. A novel, Paresthesia-Free Spinal cord Stimulation waveform for chronic neuropathic low back pain: Six-Month results of a prospective, Single-Arm, Dose-Response study. Neuromodulation Technology at the Neural Interface, 2023, 26(7): 1412-1423. https://doi.org/10.1016/j.neurom.2023.06.007.

[7] Al-Kaisy A., Palmisani S., Smith T.E., et al. Long-Term Improvements in Chronic Axial Low Back Pain Patients Without Previous Spinal Surgery: A Cohort Analysis of 10-kHz High- Frequency Spinal Cord Stimulation over 36 Months. Pain Medicine, 2018, 19(6): 1219-1226. https://doi.org/10.1093/pm/ pnx150.

[8] Reddy R.D., Deer T.R. Spinal Cord Stimulation for the Treatment of Chronic Pain: A Review of Evidence and Practice Guidelines. Journal of Pain Research, 2020, 13: 411-425. https:// doi.org/10.2147/JPR.S235116.

[9] Paresthesia-Independence: An assessment of technical factors related to 10 KHz Paresthesia-Free spinal cord stimulation. PubMed, 2017, May 1. https://pubmed.ncbi.nlm.nih. gov/28535555/#:~:text=Objectives:%20To%20determine%20 if%20pain%20relief%20was%20related%20to%20technical.

[10] Klonoff D.C., Levy B.L., Jaasma M.J., et al. Treatment of Painful Diabetic Neuropathy with 10 kHz Spinal Cord Stimulation: Long-Term Improvements in Hemoglobin A1c, Weight, and Sleep Accompany Pain Relief for People with Type 2 Diabetes. PubMed, 2024, 17: 3063-3074. https://doi. org/10.2147/jpr.s463383.

[11] Kemler M.A., Barendse G.A., Van Kleef M., et al. Spinal Cord Stimulation in Patients with Chronic Reflex Sympathetic Dystrophy. New England Journal of Medicine, 2000, 343(9): 618-624. https://doi.org/10.1056/nejm200008313430904.

[12] Ghaly L., Bargnes V., Rahman S., et al. Interventional t r e a t m e n t o f c o m p l e x r e g i o n a l p a i n s y n d r o m e . Biomedicines, 2023, 11(8): 2263. https://doi.org/10.3390/ biomedicines11082263.

[13] Harke H., Gretenkort P., Ladleif H.U., et al. Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical study. Eur. J. Pain, 2005, 9: 363-373.

[14] Bakr S.M., Knight J., Johnson S.K., et al. Spinal cord stimulation improves functional outcomes in children with complex regional pain syndrome: case presentation and review of the literature. Pain Practice, 2020, 20(6): 647-655. https://doi. org/10.1111/papr.12882.

[15] Eldabe S., Buchser E., Duarte R.V. Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature. Pain Med., 2016, 17(2): 325-336. https://doi.org/10.1093/pm/pnv025.

[16] Knotkova H., Hamani C., Sivanesan E., et al. Neuromodulation for chronic pain. Lancet, 2021, 397(10289): Dean&Francis Yuanbo Zhao 2111-2124. https://doi.org/10.1016/S0140-6736(21)00794-7.

[17] Kumar K., et al. Cost-Effectiveness of High-Frequency Spinal Cord Stimulation in Chronic Pain Management. Neuromodulation: Technology at the Neural Interface, 2021.

[18] Deer T.R., et al. High-Frequency Spinal Cord Stimulation for Pain Management: An Overview of Evidence. Journal of Pain Research, 2021.

Downloads

Published

2024-12-31

Issue

Vol. 2 No. 6 (2024): Volume 2, Issue 6

Section

Articles

License

Copyright (c) 2024 by the authors.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.